search-icon
AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Google’s $32 billion acquisition of Wiz draws antitrust attention
2
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
3
Cyberattacks against Israel surge 700% in two days, says Radware
4
Intel to begin foundry layoffs in July, but uncertainty hangs over Israel amid wartime reality
5
Andreessen Horowitz targets elite IDF alumni for startup accelerator
More news Buzzmore

Anchiano Therapeutics

1 stories about Anchiano Therapeutics
נאסד"ק וול סטריט

Anchiano Therapeutics Stock Falls on Nasdaq IPO

13.02.19|Lilach Baumer
The cancer treatment company priced its ADSs at $11.5 per unit, expecting proceeds of $30.5 million
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1